By working with researchers and industry we develop, apply and test precision medicine strategies based on genomic sequencing data.
Home of the Glasgow Cancer Assays, the Glasgow Precision Oncology Laboratory‘s purpose-built facilities, expertise and resources are aligned to maximise the speed of development of novel precision strategies in oncology.
Deputy Director and Head of Medical Genomics, Dr Susie Cooke will be speaking at the Festival of Genomics & Biodata in London on 29 January…
Our researchers are working on cancer science that really matters in the real world.
The GPOL is a purpose-built molecular profiling unit specifically designed to address the needs for large-scale discovery alongside the development, and delivery, of clinically relevant assays.
GPOL supports clinical trials, scientific research and precision medicine delivery.
Precision medicine requires the integration of a molecular pathology driven approach throughout the therapeutic development cycle.